Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,088 recruiting studies in this area right now.
By phase
- Not applicable4,195
- Phase 2595
- Phase 1411
- Phase 3325
- Phase 4251
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer336
- Cervical Cancer223
- Endometrial Cancer207
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer111
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California349
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,088 total
- NCT06912776Recruiting
Visual education tool for postpartum warning signs
This study tests a new visual education tool to help new mothers recognize and report urgent warning signs after childbirth. If you qualify, you'll learn how to spot symptoms that may need quick medical attention.
Chicago, IllinoisAges 18 years+ - NCT06914297RecruitingPhase 2
Study of TQB2450 plus progestin for uterine cancer patients wanting to keep fertility
This trial tests a combination of an immunotherapy drug (TQB2450) with a hormone treatment (progestin) for patients with a specific type of early-stage uterine cancer who wish to preserve their ability to have children. The goal is to see if this approach is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06919757Recruiting
Early Lung Health in Very Premature Infants
This study compares the early lung development of very premature babies who had growth problems in the womb to those who did not. The goal is to understand how growth in the womb affects lung health after birth.
RomaAges Any age - NCT06914726Enrolling by invitation
Cancer risk follow-up care for hereditary syndromes
This study tests a tool to help primary care doctors provide better cancer prevention care for people with hereditary breast and ovarian cancer (HBOC) or Lynch syndrome (LS). It aims to ensure you're up-to-date on recommended screenings and preventive steps.
Minneapolis, MinnesotaAges 18 years+ - NCT06918275Enrolling by invitation
Keyhole surgery for C-section scar defect repair
This study tests a keyhole surgery (laparoscopy) to repair a C-section scar defect (isthmocele). It is for women who have symptoms from the defect and want to preserve their ability to get pregnant in the future.
Istanbul, IstanbulAges 18–45 - NCT06921720Recruiting
Phosphate diabetes muscle study using phosphorus scan
This study uses a special MRI scan to look at phosphorus levels in the muscles of people with phosphate diabetes (a condition where the body loses too much phosphate through the kidneys). It aims to better understand how this condition affects muscles and may help guide future treatments.
BronAges 10 years+ - NCT06915792RecruitingPhase 4
Postpartum blood pressure medication and stopping study
This trial compares two blood pressure medicines, nifedipine and labetalol, to see which works better for new mothers with high blood pressure after giving birth. It aims to find the best way to safely stop medicine as blood pressure improves.
Los Angeles, CaliforniaAges 18–64 - NCT06919887Enrolling by invitation
App for women with menopause symptoms
This study tests whether a mobile app can help manage menopause symptoms. You may qualify if you're 45-55, speak English, have menopause symptoms, and have a Mayo Clinic appointment soon.
Rochester, MinnesotaAges 24–80 - NCT06917313RecruitingPhase 2
Fezolinetant for hot flashes in women with breast cancer on hormone therapy
This trial tests a drug called fezolinetant to see if it reduces hot flashes in women with HR+ breast cancer who are on hormone therapy (like tamoxifen or aromatase inhibitors). You need to be postmenopausal and having at least 7 moderate to severe hot flashes a day.
New Haven, ConnecticutAges 18 years+ - NCT06918067Recruiting
Comparing catheter types for urine flow
This study compares different types of catheters to see how well they help empty the bladder. If you are a woman who uses catheters regularly, you might be able to join and help improve catheter design.
Charlotte, North CarolinaAges 18 years+ - NCT05942053RecruitingPhase 4
Vitamin K2 for chronic kidney disease with high urine protein
This trial studies whether vitamin K2 can help people with chronic kidney disease (kidney damage that lasts months or longer), especially those with higher protein levels in the urine. It compares vitamin K2 use in a specific group and watches kidney-related health outcomes and safety.
Tanta, Capital of Gharbia Governorate.Ages 18 years+ - NCT06769425RecruitingPhase 1
Combination treatment for advanced solid tumors
This trial tests a new combination treatment for people with advanced solid tumors that have not responded to standard therapy. It aims to find a safe dose and see if the combination can shrink tumors.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06903247Enrolling by invitation
Ultrasound Brain Findings in Pregnancy with Low Vitamin D
This study uses ultrasound to check for differences in the baby's brain and spine in pregnant women with low vitamin D levels. It aims to see if vitamin D deficiency during pregnancy is linked to certain ultrasound findings.
SanliurfaAges 18–50 - NCT06907147Recruiting
Renal denervation for uncontrolled high blood pressure
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
Stanford, CaliforniaAges 18–80 - NCT06906341RecruitingPhase 2
Relacorilant combo for gynecologic cancers
This trial tests a drug called relacorilant combined with different treatments for ovarian, fallopian tube, primary peritoneal, or endometrial cancers. It may help patients whose cancer has stopped responding to standard therapies.
Birmingham, AlabamaAges 18 years+ - NCT06910657RecruitingPhase 1
IDOV-Immune vaccine for advanced solid tumors
This trial tests an experimental virus-based treatment for people with advanced solid tumors that have stopped responding to standard therapies. The treatment is designed to infect and destroy cancer cells while boosting the immune system.
St Louis, MissouriAges 18 years+ - NCT06902558RecruitingPhase 2
Study of ABBV-CLS-628 for adults with polycystic kidney disease
This trial tests a new drug, ABBV-CLS-628, for people with autosomal dominant polycystic kidney disease (ADPKD). The goal is to see if it slows kidney function decline and is safe to use.
Birmingham, AlabamaAges 18–55 - NCT06910813RecruitingPhase 1/Phase 2
Gene therapy trial for children with cystinosis
This trial tests a new gene therapy called DFT383 for children aged 2 to 5 with nephropathic cystinosis. It aims to see if the treatment is safe and can help improve kidney function.
Phoenix, ArizonaAges 2–5 - NCT06907303Enrolling by invitation
RNA test to help detect endometriosis
This trial uses a blood-based RNA test to detect endometriosis in women who have had trouble getting pregnant for over a year. If it works, it could provide a faster and less invasive way to diagnose the condition.
Branford, ConnecticutAges 20–35 - NCT05989438Recruiting
Different therapy models for premature babies based on the ICF biopsychosocial model
This trial compares different therapy approaches for premature babies. It aims to help with their development using the ICF biopsychosocial model, which looks at health from many angles.
Porto Alegre, Rio Grande do SulAges 4 months–2 years - NCT06360653Recruiting
Stereotactic radiation after surgery for endometrial cancer
This trial tests a precise type of radiation (stereotactic radiotherapy) given after surgery for endometrial cancer. It aims to improve treatment while reducing side effects.
PalermoAges 18–80 - NCT06901245RecruitingPhase 4
Tirzepatide for young adults with obesity
This study tests the diabetes/weight-loss drug tirzepatide (Mounjaro) in young adults aged 18–26 who have obesity and either Prader-Willi syndrome, hypothalamic obesity, or general obesity. It looks at whether a weekly injection can help with weight management.
Saint Paul, MinnesotaAges 18–26 - NCT06907667Recruiting
Do timing of flu shot affect protection in kidney failure?
This study looks at whether getting a flu shot at a different time of day affects how well it works in people with chronic kidney failure, including those on dialysis or with a kidney transplant. Researchers want to see if timing can improve the body's immune response to the vaccine.
Nice, Alpes-MaritimesAges 18–100 - NCT06904365Recruiting
Ovarian-sparing radiation for young women
This study tests a way to give radiation therapy that avoids the ovaries as much as possible, to help preserve fertility and hormone function in young women.
St Louis, MissouriAges 18–50
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,088 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,891 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.